The results of Tervahartiala et al. [14] verified also their previous studies where they could demonstrate that CD68 and MAC387 are associated with poorer survival in bladder cancer patients, whereas CLEVER-1-positive vessels act more as a protective marker [32]. Here, S100A9 is linked to urinary bladder carcinoma.